Cargando…
Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
Standard treatments for gynecological cancers include surgery, chemotherapy, and radiation therapy. However, there are limitations associated with the chemotherapeutic drugs used to treat advanced and recurrent gynecological cancers, and it is difficult to identify additional treatments. Therefore,...
Autores principales: | Lee, Seon-Mi, Lee, Sanghoon, Cho, Hyun-Woong, Min, Kyung-Jin, Hong, Jin-Hwa, Song, Jae-Yun, Lee, Jae-Kwan, Lee, Nak-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865129/ https://www.ncbi.nlm.nih.gov/pubmed/36674491 http://dx.doi.org/10.3390/ijms24020974 |
Ejemplares similares
-
Update on immune checkpoint inhibitors in gynecological cancers
por: Heong, Valerie, et al.
Publicado: (2017) -
Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment
por: Pirš, Boštjan, et al.
Publicado: (2022) -
Checkpoint inhibitors: What gastroenterologists need to know
por: Ahmed, Monjur
Publicado: (2018) -
Depressed Mood as a Significant Risk Factor for Gynecological Cancer Aggravation
por: Lee, Seon-Mi, et al.
Publicado: (2023) -
Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)